New Type Of Drug To Prevent Migraines Heads To Market
An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.
by Richard Harris
May 18, 2018
2 minutes
The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines among people prone to these sometimes crippling headaches.
That's welcome news to some of the millions of Americans who suffer from these . Much more common in women than
You’re reading a preview, subscribe to read more.
Start your free 30 days